Stay in touch
We'd love to keep in touch about news, events and how you can get involved. To hear from us, please sign up below.
1. What is osteoporosis?
2. What causes osteoporosis?
3. Breast cancer treatments and bone health
4. What is a DEXA scan and do I need one?
5. What is osteopenia?
6. What is my fracture risk?
7. Can osteoporosis be prevented or treated?
8. Further support
Osteoporosis is a condition where your bones lose their strength and thickness (density). This leads to bones becoming weaker and more likely to break (fracture).
Bones have a thick outer shell and a strong inner mesh filled with collagen (protein), calcium salts and other minerals. The inside looks like a honeycomb, with blood vessels and bone marrow in the spaces between.
Osteoporosis means some of the outside and inside of the bone become thin. Sometimes the structure starts to break down causing wider spaces, and bones can fracture easily with little or no force.
Generally, osteoporosis causes no pain or symptoms, so often a person will not realise they have the condition until a fracture happens. The most common sites for a fracture are the wrist, hip and back (spine).
Although osteoporosis cannot be cured, treatments are available to try to keep the bones strong and less likely to fracture.
Your risk of getting osteoporosis is increased by:
Our bones increase in density and strength until we reach our late 20s. Around the age of 35 we start to lose bone density as part of the natural ageing process. This happens gradually over time but is much more significant after the menopause.
The hormone oestrogen protects against bone loss and helps to keep bones strong. Women who have gone through the menopause are at increased risk of osteoporosis and fractures because their ovaries no longer produce oestrogen, although small amounts of oestrogen are still produced by fat cells.
Women may also have low levels of oestrogen because of:
Other risk factors for osteoporosis and fractures include:
Certain lifestyle factors can make you more likely to have low bone density, such as regularly drinking more than the recommended amount of alcohol, smoking or a diet that is low in calcium and vitamin D.
Some breast cancer treatments can lower bone density and increase the risk of osteoporosis and fractures in both premenopausal women (women who have not gone through the menopause) and postmenopausal women (women who have gone through the menopause).
The likelihood of developing osteoporosis and having fractures will also depend on how healthy your bones were before your breast cancer treatment.
Women aged 45 or under whose periods have stopped for at least a year as a result of treatment may also be at risk of osteoporosis, even if their periods restart.
Some research has shown that postmenopausal women who have chemotherapy may have greater loss of bone density than they would have had without chemotherapy.
Ovarian suppression is when the ovaries are stopped from working (suppressed), either temporarily or permanently. This means there is less oestrogen in the body to help the cancer to grow. However, having less oestrogen in the body can also reduce bone density.
Tamoxifen blocks the effect of oestrogen on cancer cells.
Tamoxifen may slightly increase the risk of osteoporosis for premenopausal women. This is unlikely to lead to osteoporosis, unless ovarian suppression is given as well. However, your risk may be higher if you’re 45 or under and your periods have stopped for at least a year.
In postmenopausal women, taking tamoxifen slows down bone loss and can reduce the risk of osteoporosis.
They are usually used to treat breast cancer in postmenopausal women, but some premenopausal women take an aromatase inhibitor at the same time as having ovarian suppression. Having these two treatments together can reduce bone density.
If your treatment team is concerned about your risk of developing osteoporosis and fractures, they may suggest a DEXA (dual energy x-ray absorptiometry) scan or DXA scan to check your bone strength before you start treatment.
The DEXA scan measures bone mineral density (BMD). BMD is the amount of calcium and other minerals in an area of bone and is a measurement of bone strength. The lower your BMD, the more likely osteoporosis will be diagnosed.
A DEXA scan uses a very small amount of radiation and is quick and painless. While you are lying down, an open x-ray scanner will pass over your body taking pictures of your hips and sometimes lower spine. Your results will include a T score. The T score measures how your BMD compares to a range of young healthy adults with average BMD.
The BMD score ranges:
Find out more about DEXA scans on the Royal Osteoporosis Society website.
Follow-up DEXA scans may be repeated after two to five years for some people. However, if you are taking an osteoporosis drug treatment and having no side effects and you have not had any fractures while taking it, then it is likely that the drug is working, and you will not need regular DEXA scans.
Your treatment team may follow guidance produced by NICE (National Institute for Health and Care Excellence) when deciding if you need a DEXA scan. However, this only applies to England. Assessment and treatment may be different in Wales, Scotland or Northern Ireland, your treatment team can tell you more about this.
Some people’s results from the DEXA scan may show they have decreased bone density, but not enough to be classed as osteoporosis. This is called osteopenia.
If you have osteopenia, you may have a higher risk of fractures and some people will go on to develop osteoporosis. However, osteopenia does not always lead to osteoporosis. Osteopenia does not usually have any symptoms.
If you have osteopenia with no other risk factors you will be given advice about changes you can make to your lifestyle, such as diet and exercise. You may also be advised to stop or cut down smoking and limit your alcohol intake. You won’t usually need treatment.
If you have osteopenia and you are also taking an aromatase inhibitor you may be given treatment to reduce your risk of fracture. Your doctor will discuss this with you.
Research has shown that your risk of breaking a bone (fracture risk) can be assessed by including other risk factors. For example:
When assessing your fracture risk, your doctor will take these factors into account as well as your BMD score. They may use an online fracture risk assessment tool such as FRAX or Qfracture to predict your risk of fracture over a period of time and help decide if you need treatment. These tools are designed for the general population and do not take into account breast cancer treatment.
Some people are more at risk of fracture than others. The lifestyle changes mentioned below and treatments to strengthen bones can reduce your risk.
Many fractures are the result of having a fall. If you are over 65 there is a self-assessment test to check if you are at risk of falling on the NHS website. You can discuss the result of this test and how best to manage your risk with your GP.
You can read their guide Get up and go: a guide to staying steady.
A cancer centre based in the US has also produced an online educational tool to promote bone health in people who have been treated for breast cancer.
There are a range of ways to prevent and reduce further bone loss:
Although osteoporosis cannot be cured, treatments are available to try to stop the bones losing more bone density and to make them less likely to fracture. You will be advised about any appropriate drug treatment and its possible side effects. The Royal Osteoporosis Society has more information on drugs to prevent and treat osteoporosis.
Your GP may recommend a calcium and vitamin D supplement. You may be prescribed a tablet that contains both, such as Adcal D3.
Bisphosphonates are usually given to people who have had breast cancer to treat osteoporosis. This includes alendronate, zoledronic acid, risedronate and ibandronate.
Bisphosphonates help strengthen your bones and reduce your risk of fractures. They can be given as a tablet or as an injection into the vein. They may also be prescribed to protect your bones if you’re taking an aromatase inhibitor (such as exemestane, letrozole or anastrozole). Bisphosphonates may be used as a treatment to reduce the risk of primary breast cancer spreading. They are also sometimes given as a treatment for secondary breast cancer in the bone. This is not the same as having osteoporosis.
Denosumab is a drug that may be recommended to reduce the risk of fractures. It is given as an injection twice a year and slows down bone loss in osteoporosis. It’s a treatment for postmenopausal women who are unable to take certain bisphosphonates.
Raloxifene is given for the prevention and treatment of osteoporosis in postmenopausal women. Raloxifene is only prescribed for women who have had breast cancer after they have completed their breast cancer treatment.
Teriparatide is also prescribed for osteoporosis but is usually only recommended if you are unable have bisphosphonates or denosumab. It may be suggested if you have a very high risk of fracture, particularly of the spine.
If you are concerned about osteoporosis and breast cancer or have questions about treatment you can talk to our Helpline team on 0808 800 6000.
You can also visit our online Forum for emotional and practical support.